[Effect of Panax notoginseng saponins combined isovolumic haemodilution on the retinal microcirculation of patients with retinal vein occlusion].
OBJECTIVE
To study the effect of Panax notoginseng saponins (PNS) or isovolumic haemodilution (IHD) and combination of PNS with IHD on retinal microcirculation of patients with retinal vein occlusion (RVO).


METHODS
Seventy three patients with RVO were allocated at random to three groups which were treated with PNS, IHD, or PNS + IHD respectively. The retinal circulation time (RCT) and retinal hemorrhage, edema, leakage of capillary, cystoid macular edema (CME), and nonperfusion area of capillary in retina were observed before and after treatment.


RESULTS
RCT of patients with RVO was shortened by three treating methods. RCT in the patients who treated by PNS + IHD was the shortest, especially in the patients with nonischemic RVO and branch retinal vein occlusion(BRVO). The retinal hemorrhage, edema, leakage of capillary, and CME in the patients treated by PNS + IHD disappeared quicker than those treated by PNS or IHD. At the same time, the incidence of nonperfusion area in patients whose course of disease was shorter than fourteen days was decreased. The perfusion of capillaries was increased at the edge of nonperfusion area which existed before the treatment. But the effect for nonperfusion area which existed before the treatment in the type of ischemic RVO was not obvious.


CONCLUSIONS
The treatment of PNS + IHD can both shorten RCT of patients with RVO, and promote absorption of retinal hemorrhage, edema, leakage of capillary, and CME. It is possible that PNS + IHD treatment also has an effect to decrease the forming of nonperfusion area in patients whose course of disease is at early stage.
Department of Ophthalmology, Second Affiliated Hospital, Hunan Medical University, Changsha 410011.
X H
XH
Xi
D Y
DY
Jiang
C Z
CZ
Tang
J Q
JQ
Tan
A G
AG
Nie
D005260:Female; D006438:Hemodilution; D006801:Humans; D008297:Male; D008833:Microcirculation / Q000187:drug effects; D005894:Panax / Q000737:chemistry*; D008517:Phytotherapy; D012170:Retinal Vein Occlusion / Q000503:physiopathology / Q000628:therapy*; D012171:Retinal Vessels; D012503:Saponins / Q000627:therapeutic use*; D014665:Vasodilator Agents / Q000627:therapeutic use*
D012503:Saponins; D014665:Vasodilator Agents